Variables | Total number | TGase 2 expression | p-value | ||
---|---|---|---|---|---|
 |  | Negative | Intermediate | Strong |  |
Histology | Â | Â | Â | Â | Â |
Adenocarcinoma | 193 (45) | 74(38) | 58(30) | 61(32) | <0.001 |
Squamous carcinoma | 198 (46) | 155(78) | 26(13) | 17(9) | Â |
Others* | 38 (9) | 19(50) | 9(24) | 10(26) | Â |
Differentiation** | Â | Â | Â | Â | Â |
Well | 61 (18) | 41(67) | 11(18) | 9(15) | 0.474 |
Moderate | 200 (58) | 122(61) | 41(21) | 37(19) | Â |
Poorly | 87 (25) | 47(54) | 18(21) | 22(25) | Â |
Gender | Â | Â | Â | Â | Â |
Male | 324 (76) | 206(64) | 58(18) | 60(19) | <0.001 |
Female | 105 (24) | 42(40) | 35(33) | 28(27) | Â |
Smoking | Â | Â | Â | Â | Â |
Nonsmoker | 113 (26) | 44(39) | 35(31) | 34(30) | <0.001 |
Ex-smoker | 120 (28) | 86(72) | 15(13) | 19(16) | Â |
Current Smoker | 196 (46) | 118(60) | 43(22) | 35(18) | Â |
T-stage*** | Â | Â | Â | Â | Â |
1 | 81 (19) | 40(50) | 16(20) | 25(31) | 0.037 |
2 | 277 (65) | 161(58) | 67(24) | 49(18) | Â |
3-4 | 70 (16) | 47(67) | 10(14) | 13(19) | Â |
N-stage | Â | Â | Â | Â | Â |
0 | 257 (60) | 148(58) | 55(21) | 54(21) | 0.414 |
1 | 93 (22) | 53(57) | 17(18) | 23(25) | Â |
2-3 | 79 (18) | 47(60) | 21(27) | 11(14) | Â |
Recurrence event | Â | Â | Â | Â | Â |
No | 259 (60) | 165(64) | 52(20) | 42(16) | 0.005 |
Yes | 170 (40) | 83(49) | 41(24) | 46(27) | Â |
Recurrence in male patients | Â | Â | Â | Â | Â |
No | 203 (47) | 141(69) | 33(16) | 29(14) | Â |
Yes | 121 (28) | 65(54) | 25(21) | 31(26) | 0.011 |
Recurrence in female patients | Â | Â | Â | Â | Â |
No | 56 (53) | 24(42) | 19(34) | 13(23) | 0.672 |
Yes | 49 (47) | 18(37) | 16(33) | 15(31) | Â |
Recurrence in patients with adenocarcinoma | Â | Â | Â | Â | Â |
No | 102 (53) | 43(42) | 29(28) | 30(29) | 0.512 |
Yes | 91 (47) | 31(34) | 29(32) | 31(34) | Â |
Recurrence in patients with non-adenocarcinoma | Â | Â | Â | Â | Â |
No | 157 (67) | 122(78) | 23(15) | 12(8) | 0.031 |
Yes | 79 (33) | 52(66) | 12(15) | 15(19) | Â |